Life Science Real Estate Boom: Golden Investment Opportunities for Investors
Discover How Specialised Buildings Are Transforming Commercial Real Estate and Unveiling Lucrative Investment Prospects
Dear Readers,
A warm welcome to all the new subscribers that join over the last week. I hope you enjoy this issue all about Life Science Real Estate.
I’m always open to honest and constructive feedback on my writing so please feel free to either comment or send me a DM.
Best,
Carlo
Today's newsletter explores the surge in life science buildings as an alternative asset class to traditional office spaces. We'll dive into their key characteristics and why they are an attractive investment proposition.
Life science buildings are more than just real estate assets; they're the cornerstone of medical innovation. These facilities support the research, development, and manufacturing of cutting-edge medical treatments, pharmaceuticals, and biotechnology products.
This translates to:
Stable, long-term tenants.
Higher rental yields compared to traditional office spaces.
Potential for value appreciation as the sector grows.
By investing in life science buildings, you are not only acquiring property but also fueling scientific research and achieving significant returns.
The map visualises life science occupiers, top universities and leading hospitals within selected European markets (Belgium, Denmark, Czech Republic, Denmark, Italy, Ireland, France, Germany, Netherlands, Poland, Portugal, Spain, Sweden, Switzerland). It includes hospitals ranked within the top 150 globally (Statista, 2022) and universities within the top 200 globally for life sciences (Times Higher Education World University Rankings 2023).
The life sciences industry has experienced exponential growth, driven by advancements in biotechnology, gene therapy, and cell-based therapies. This growth has catalyzed a surge in demand for purpose-built, high-quality facilities.
This means:
Increased development opportunities in key markets.
Strong demand from both established companies and startups.
Potential for premium rents due to specialised nature of facilities.
The crisis of the conventional office asset class tipped many asset owners and developers to pivot to building lab spaces. In the UK, the life science sector received government backing, creating a surge in developments.
“Chancellor reveals life sciences growth package to fire up economy” - UK Government.
In London, the vacancy rates for fitted lab space are below 1% due to the high demand and low supply. This is driving rents for lab space in the city close to £100 / sqft in prime areas.
Many life science buildings are strategically located within "innovation districts" – geographic clusters that foster collaboration between research institutions, startups, and established companies.
Now, let’s dive in.
1. Key Characteristics of Life Science Buildings
On the outside, a life science building might look like any other conventional office building. However, these buildings have unique features that investors and developers should understand.
Beyond their scientific function, these buildings are alternative workplaces that priorities:
Health and Wellbeing.
Communal spaces to foster innovation.
Flexibility to accommodate changing research needs.
These features help attract and retain top talent. They potentially also help reduce vacancy rates, making an investment more valuable.
The key technical specifications for a Life Science building include all the common features of conventional offices plus the following upgraded technical characteristics:
Higher structural loading zones for the Lab spaces.
Flexible, adaptable layouts for evolving research needs.
Minimum Containment Level 2 (CL2) for handling sensitive materials.
High floor-to-floor heights (4.5m) to accommodate complex MEP systems.
Robust building services including redundant power and advanced HVAC systems.
While these specifications often result in higher construction costs (typically 15-30% more than traditional office buildings), they also command premium rents, often 30-50% higher than conventional office spaces in the same market.
2. Leading Players in the Market
Companies like Kadans Science Partner and Galileo Global Education are leading developers and operators of life science buildings. These specialized firms understand the unique requirements of the life sciences industry and work closely with tenants to create tailored, high-performance facilities.
Kadans focuses on investing, developing, and operating facilities within established science and technology clusters across Europe. Kadans takes a "community-centric" approach, aiming to connect tenants, provide value-added services, and leverage its global network of science clusters.
“Kadans Science Partner focuses on bringing people together to overcome global challenges.” - Kadans Science Partner
Galileo Global Education is a major international education group that has expanded into the life science real estate sector. Galileo Labs develops and operates specialized laboratory and office buildings to support the growth of the life sciences industry. By integrating education and real estate, Galileo Labs aims to foster collaboration and knowledge-sharing within its life science ecosystems.
Investment Tip: Consider partnering with experienced operators or investing in REITs focused on life science properties for diversified exposure to this growing sector.
3. Development and Leasing Strategies
For developers and asset owners, understanding the unique requirements of life science tenants is crucial:
"Cat-B" finished spaces: Tenants expect move-in ready facilities with specialised infrastructure.
Amenities that support research: Consider offering shared lab equipment or conference facilities.
Flexible lease terms: Many biotech startups prefer shorter lease periods with expansion options.
Ensure you build a cross-functional team of consultants with deep expertise in Life Science. This will ensure the development meets industry standards and is well positioned in the market.
Engage early with occupiers and third-party operators to ensure the product fulfills market demands.
Partner with life science consultants to ensure your development meets industry standards and attracts top-tier tenants.
Landlords can decide to either self-operate or partner with a third-party operator. The advantage of using a third-party is the opportunity to leverage specialized expertise and provide value-added services to tenants.
4. Case Studies: Successful Projects
Canary Wharf in London has decisively invested in the life science sector since the Covid pandemic. The estate anticipated the traditional office sector's challenges and seized the opportunity to reposition a portion of its assets to provide life science facilities.
Kadans Science Partner is developing Europe’s largest life science facility in partnership with Canary Wharf Group:
500,000 square feet – UK and Europe’s largest life science building.
State-of-the-art R&D spaces with cutting-edge amenities.
Attracted major pharmaceutical companies as anchor tenants.
This project represents a major investment in Life Science for Canary Wharf Group and will provide state of the art facilities attracting leading occupiers in the sector.
5. Market Outlook and Investment Strategies
The life science real estate sector shows strong growth potential:
Vacancy rates in top life science clusters like London are below 5%.
Rent premium compared to traditional office space (30-50%).
Average rents continue to grow (3-5% year-on-year).
R&D transaction volume increased from 4.6% to 5.8% of total commercial real estate transactions.
'It is an old saying, abundantly justified, that where sciences meet there growth occurs.' - Sir Frederick Gowland Hopkins
Potential investment strategies:
Direct acquisition of existing life science buildings in established hubs.
Development of new facilities in emerging biotech markets.
Conversion of traditional office spaces to life science use (typically costs $135-400 per square foot).
Risk Considerations:
Higher upfront costs for specialised infrastructure.
Potential for rapid technological changes affecting building requirements.
Concentration risk in specific geographic clusters.
Conclusion: Seizing the Opportunity
Life science buildings represent a dynamic and growing sector within commercial real estate. As the industry continues to expand, driven by technological advancements and increased funding, the demand for specialised, high-performance facilities will only increase.
For savvy investors, asset owners, and developers, this presents a unique opportunity to:
Diversify portfolios with high-yielding assets.
Capitalize on a sector with strong growth prospects.
Contribute to groundbreaking advancements in healthcare and biotechnology.
That’s all for today.
See you next week.
Support Unlocking Real Estate Value!
Consider upgrading to a paid subscription to show your appreciation for my writing and support the Newsletter. I’m working on a series of exclusive resources that paid subscribers will get access to.
Other ways I can help you.
Do you need help focusing the development strategy for a project?
I can help you brainstorm an idea or with real estate market advice.